Benitec Biopharma Inc (BNTC)
9.48
-0.33
(-3.36%)
USD |
NASDAQ |
Oct 04, 16:00
9.40
-0.08
(-0.84%)
After-Hours: 20:00
Benitec Biopharma Research and Development Expense (Annual): 15.61M for June 30, 2024
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 15.61M |
| June 30, 2023 | 12.77M |
| June 30, 2022 | 11.27M |
| June 30, 2021 | 7.02M |
| June 30, 2020 | 3.001M |
| June 30, 2019 | 4.567M |
| Date | Value |
|---|---|
| June 30, 2018 | 5.061M |
| June 30, 2017 | 5.322M |
| June 30, 2016 | 9.922M |
| June 30, 2015 | 4.777M |
| June 30, 2014 | 5.864M |
| June 30, 2013 | 3.430M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.001M
Minimum
2020
15.61M
Maximum
2024
9.935M
Average
11.27M
Median
2022
Research and Development Expense (Annual) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.31M |
| Oragenics Inc | 15.49M |